{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:49:38Z","timestamp":1761061778960,"version":"build-2065373602"},"reference-count":19,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematology Reports"],"abstract":"<jats:p>Purpose: To describe a patient with sickle cell disease, a prothrombotic disorder, who underwent successful embryo cryopreservation for the purposes of fertility preservation prior to hematopoietic stem cell transplant. Methods: To report a successful case of gonadotropin stimulation and embryo cryopreservation using the aromatase inhibitor letrozole to maintain low serum estradiol to minimize thrombotic risk in a patient with sickle cell disease (SCD) and history of retinal artery thrombosis planning hematopoietic stem cell transplant (HSCT). The patient was given letrozole (5 mg daily) as well as prophylactic enoxaparin while undergoing gonadotropin stimulation with an antagonist protocol to preserve fertility prior to HSCT. After the oocyte retrieval, letrozole was continued for one additional week. Results: The patient\u2019s peak serum estradiol concentration was 172 pg\/mL during gonadotropin stimulation. Ten mature oocytes were retrieved and a total of 10 blastocysts were cryopreserved. The patient required pain medication and intravenous fluids after oocyte retrieval due to pain but had significant improvement at the scheduled post-operative day one follow-up. No embolic events occurred during stimulation or 6 months thereafter. Conclusion: The utilization of definitive treatment for SCD with stem cell transplant is increasing. We successfully used letrozole to maintain low serum estradiol during gonadotropin stimulation along with prophylactic enoxaparin in a patient with SCD to minimize her risk of thrombosis. This approach will allow patients planning definitive treatment with stem cell transplant the opportunity to preserve their fertility safely.<\/jats:p>","DOI":"10.3390\/hematolrep15010011","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T03:36:57Z","timestamp":1675395417000},"page":"101-107","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Embryo Cryopreservation in a Patient with Sickle Cell Disease Utilizing Letrozole and Enoxaparin: A Case Report"],"prefix":"10.3390","volume":"15","author":[{"given":"Stephanie J.","family":"Gunderson","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Snowden","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua J.","family":"Field","sequence":"additional","affiliation":[{"name":"Department of Hematology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"},{"name":"Versiti Blood Center of Wisconsin, Milwaukee, WI 53233, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.clml.2013.05.014","article-title":"Impact of reduced-intensity conditioning allogeneic stem cell transplantation on women\u2019s fertility","volume":"13","author":"Assouline","year":"2013","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/17474086.2017.1367279","article-title":"Fertility challenges for women with sickle cell disease","volume":"10","author":"Ghafuri","year":"2017","journal-title":"Expert Rev. Hematol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Nickel, R.S., Maher, J.Y., Hsieh, M.H., Davis, M.F., Hsieh, M.M., and Pecker, L.H. (2022). Fertility after Curative Therapy for Sickle Cell Disease: A Comprehensive Review to Guide Care. J. Clin. Med., 11.","DOI":"10.3390\/jcm11092318"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Boga, C., Asma, S., Ozer, C., Bulgan Kilicdag, E., Kozanoglu, I., Yeral, M., Korur, A., Gereklioglu, C., and Ozdogu, H. (2022). Gonadal Status and Sexual Function at Long-Term Follow-up after Allogeneic Stem Cell Transplantation in Adult Patients with Sickle Cell Disease. Exp. Clin. Transplant.","DOI":"10.6002\/ect.2021.0392"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/humrep\/14.3.787","article-title":"Endometrial pinopodes indicate a shift in the window of receptivity in IVF cycles","volume":"14","author":"Nikas","year":"1999","journal-title":"Hum. Reprod."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0002-9378(87)80129-1","article-title":"Coagulation effects of oral contraception","volume":"157","author":"Bonnar","year":"1987","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.fertnstert.2018.05.016","article-title":"Risks associated with fertility preservation for women with sickle cell anemia","volume":"110","author":"Pecker","year":"2018","journal-title":"Fertil. Steril."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s10815-017-1008-1","article-title":"Acute pain crisis in a patient with sickle cell disease undergoing ovarian stimulation for fertility preservation prior to curative stem cell transplantation: Case report and literature review","volume":"34","author":"Matthews","year":"2017","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10815-011-9698-2","article-title":"Oocyte cryopreservation in a patient with sickle cell disease prior to hematopoietic stem cell transplantation: First report","volume":"29","author":"Dovey","year":"2012","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_10","first-page":"287","article-title":"Fertility preservation before hematopoetic stem cell transplantation: A case series of women with GATA binding protein 2 deficiency, dedicator of cytokinesis 8 deficiency, and sickle cell disease","volume":"1","author":"Aserlind","year":"2020","journal-title":"FS Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.fertnstert.2013.03.029","article-title":"Ovarian stimulation in cancer patients","volume":"99","author":"Cakmak","year":"2013","journal-title":"Fertil. Steril."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.fertnstert.2012.09.022","article-title":"Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer","volume":"98","author":"Reddy","year":"2012","journal-title":"Fertil. Steril."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.rbmo.2010.03.004","article-title":"GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor\/FSH stimulation","volume":"20","author":"Oktay","year":"2010","journal-title":"Reprod. Biomed. Online"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Practice Committee of the American Society for Reproductive Medicine (2016). Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: A guideline. Fertil. Steril., 106, 1634\u20131647.","DOI":"10.1016\/j.fertnstert.2016.08.048"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.fertnstert.2012.03.015","article-title":"Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders","volume":"97","author":"Griffin","year":"2012","journal-title":"Fertil. Steril."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/humrep\/dei029","article-title":"Treatment option for sperm- or oocyte-related fertilization failure: Assisted oocyte activation following diagnostic heterologous ICSI","volume":"20","author":"Heindryckx","year":"2005","journal-title":"Hum. Reprod."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"751373","DOI":"10.3389\/fendo.2021.751373","article-title":"Development of Nomograms to Predict Blastulation Rate Following Cycles of In Vitro Fertilization in Patients with Tubal Factor Infertility, Polycystic Ovary Syndrome, or Endometriosis","volume":"12","author":"Haixia","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5935\/1518-0557.20150025","article-title":"Percentage of Blastulation on the Number and Function of Metaphase II Oocytes","volume":"19","author":"Chadid","year":"2015","journal-title":"JBRA Assist. Reprod."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.rbmo.2009.12.027","article-title":"Reduction in exposure of human embryos outside the incubator enhances embryo quality and blastulation rate","volume":"20","author":"Zhang","year":"2010","journal-title":"Reprod. Biomed. Online."}],"container-title":["Hematology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2038-8330\/15\/1\/11\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:22:59Z","timestamp":1760120579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2038-8330\/15\/1\/11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["hematolrep15010011"],"URL":"https:\/\/doi.org\/10.3390\/hematolrep15010011","relation":{},"ISSN":["2038-8330"],"issn-type":[{"type":"electronic","value":"2038-8330"}],"subject":[],"published":{"date-parts":[[2023,2,3]]}}}